Northern Trust’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,587
Closed -$83.3K 4516
2024
Q3
$83.3K Sell
4,587
-12,217
-73% -$213K ﹤0.01% 4100
2024
Q2
$405K Sell
16,804
-683
-4% -$21.2K ﹤0.01% 3581
2024
Q1
$762K Buy
17,487
+385
+2% +$15.9K ﹤0.01% 3413
2023
Q4
$698K Sell
17,102
-439
-3% -$23.9K ﹤0.01% 3431
2023
Q3
$1.45M Sell
17,541
-252
-1% -$22.9K ﹤0.01% 3106
2023
Q2
$1.69M Sell
17,793
-435
-2% -$55.8K ﹤0.01% 3102
2023
Q1
$2.52M Sell
18,228
-88
-0.5% -$8.05K ﹤0.01% 2841
2022
Q4
$1.31M Sell
18,316
-1,941
-10% -$184K ﹤0.01% 3170
2022
Q3
$2.39M Sell
20,257
-17
-0.1% -$3.03K ﹤0.01% 2919
2022
Q2
$3.7M Sell
20,274
-722
-3% -$131K ﹤0.01% 2698
2022
Q1
$4.92M Sell
20,996
-705
-3% -$142K ﹤0.01% 2591
2021
Q4
$7.4M Buy
21,701
+5,447
+34% +$3M ﹤0.01% 2451
2021
Q3
$10.6M Buy
16,254
+9,780
+151% +$7.19M ﹤0.01% 2224
2021
Q2
$6.49M Buy
6,474
+3,527
+120% +$3.52M ﹤0.01% 2677
2021
Q1
$4.45M Buy
2,947
+2,289
+348% +$3.72M ﹤0.01% 2831
2020
Q4
$619K Buy
+658
New +$353K ﹤0.01% 3663

Other funds holding DNMR

Northern Trust's DNMR Position: Q4 2024 in Review

Northern Trust sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 4,587 shares — an estimated $83.3K sold.

Northern Trust first reported a position in DNMR in Q4 2020 and held it in 16 quarters. The position peaked at $10.6M in Q3 2021. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.

  • Northern Trust reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
  • Northern Trust sold 4,587 Danimer Scientific, Inc. shares in Q4 2024, an estimated $83.3K.
  • Northern Trust first reported a position in Danimer Scientific, Inc. in Q4 2020 and held it in 16 quarters.
  • Northern Trust's Danimer Scientific, Inc. position peaked at $10.6M in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.

Based on Northern Trust's 13F filing for Q4 2024, filed 14 Feb 2025.